학술논문

EFFICACY OF IDELALISIB IN CLL SUBPOPULATIONS HARBORING DEL(17P) AND OTHER ADVERSE PROGNOSTIC FACTORS: RESULTS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Document Type
Journal
Source
LEUKEMIA RESEARCH; OCT 2014, 38 pS44-pS45, 2p. Supplement: 1
Subject
Language
English
ISSN
01452126